This index is particularly useful for healthcare professionals, researchers, and individuals seeking detailed information about specific branded pharmaceutical product.
Monographs serve as essential reference for clinical particulars such as drug composition and administration guidelines, indications, contraindications and adverse reactions.
| Document | Type | Information Source | |
|---|---|---|---|
| ORACORT Paste | MPI, EU: SmPC | Web Search | |
| ORAJEL Dental gel | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ORALAIR Tablets | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ORALDENE Mouthwash | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ORAP Tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ORATANE Soft capsule | MPI, EU: SmPC | Medicines and Medical Devices Safety Authority (NZ) | |
| ORAVERSE Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ORBACTIV Powder for solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ORCIPRENALINE Syrup | MPI, CA: SPM | Health Products and Food Branch (CA) | |
| ORDSPONO Concentrate for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORELOX Film-coated tablet / Granules | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| ORENCIA Powder for concentrate for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORENCIA Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORFADIN Capsule / Oral suspension | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ORGALUTRAN Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORGAMETRIL Tablet | MPI, EU: SmPC | ||
| Orgaran | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ORGOVYX Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ORGOVYX Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORILISSA Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ORKAMBI Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORKAMBI Granules | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORLADEYO Hard capsule | MPI, EU: SmPC | European Medicines Agency (EU) | |
| OROXINE Tablet | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| ORPHACOL Hard capsule | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORPHENADRINE CITRATE Extended release tablet | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| ORPHENADRINE CITRATE Solution for injection | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| ORPHENADRINE HYDROCHLORIDE Oral solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ORSERDU Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| ORSERDU Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ORUDIS SR Capsule | MPI, EU: SmPC | Pharmaceutical Benefits Scheme (AU) | |
| ORUVAIL Controlled release capsule | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ORUVAIL Gel | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.